UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Measurement of cortisol in serum and saliva

Author
Lynnette K Nieman, MD
Section Editor
André Lacroix, MD
Deputy Editor
Kathryn A Martin, MD

INTRODUCTION

Measurements of cortisol in serum (or occasionally plasma) are extremely useful in the diagnosis of hypercortisolism and adrenal insufficiency. It is important to appreciate the many factors that can affect the serum cortisol concentration and in particular the episodic secretion of cortisol and the resulting diurnal variation in serum cortisol, which makes the interpretation of a single value hazardous. Measurements of the salivary cortisol may offer some advantages over measurements of serum cortisol. Methods of interpretation of cortisol assays will be reviewed here. Their use in the diagnosis of adrenal disorders is reviewed separately. (See "Establishing the diagnosis of Cushing's syndrome" and "Diagnosis of adrenal insufficiency in adults".)

MEASUREMENT OF SERUM CORTISOL

Cortisol has been measured in serum by several methods. Although many of them are no longer in routine use, the important assays are mentioned to permit one to interpret the older literature.

Methods of measurement

Porter-Silber chromogens — Serum cortisol was first measured by assay of Porter-Silber chromogens (17,21-dihydroxy-20-ketosteroids, referred to as 17-hydroxycorticosteroids, or 17-OHCS) [1]. This method is no longer used.

Competitive protein-binding assay — This assay uses competition for binding sites on cortisol-binding globulin (CBG, or transcortin) to quantify cortisol [2,3]. Its advantage is lack of drug interference; its disadvantage is that prednisolone and several endogenous steroids, some of which may be increased in pregnancy, adrenal carcinoma, congenital adrenal hyperplasia, and after administration of adrenal enzyme inhibitors, bind to CBG and falsely elevate serum cortisol values. Interfering steroids can be removed before assay by solvent partition or thin layer chromatography (TLC).

Fluorometric assay — This assay exploits the fluorescence of 4-11-beta, 21-dihydroxy-3,20-ketosteroids (11-hydroxycorticosteroids, or 11-OHCS) in sulfuric acid and alcohol [4]. Cortisol and corticosterone are detected by this assay; potent synthetic glucocorticoids are not. Its advantages are simplicity and relative specificity; its disadvantage is that spironolactone, quinine, quinidine, niacin, and benzoyl alcohol also fluoresce in those solvents and therefore falsely elevate cortisol values.

                          

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Wed Jan 30 00:00:00 GMT+00:00 2013.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. NELSON DH, SAMUELS LT. A method for the determination of 17-hydroxycorticosteroids in blood; 17-hydroxycorticosterone in the peripheral circulation. J Clin Endocrinol Metab 1952; 12:519.
  2. Murphy BE. Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. J Clin Endocrinol Metab 1967; 27:973.
  3. Murphy BE. Non-chromatographic radiotransinassay for cortisol: application to human adult serum, umbilical cord serum, and amniotic fluid. J Clin Endocrinol Metab 1975; 41:1050.
  4. MATTINGLY D. A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. J Clin Pathol 1962; 15:374.
  5. Ballard PL, Carter JP, Graham BS, Baxter JD. A radioreceptor assay for evaluation of the plasma glucocorticoid activity of natural and synthetic steroids in man. J Clin Endocrinol Metab 1975; 41:290.
  6. Guo T, Taylor RL, Singh RJ, Soldin SJ. Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin Chim Acta 2006; 372:76.
  7. Taylor RL, Grebe SK, Singh RJ. Quantitative, highly sensitive liquid chromatography-tandem mass spectrometry method for detection of synthetic corticosteroids. Clin Chem 2004; 50:2345.
  8. Gotelli GR, Wall JH, Kabra PM, Marton LJ. Fluorometric liquid-chromatographic determination of serum cortisol. Clin Chem 1981; 27:441.
  9. Gore M, Lester E. Comparison of a fluorimetric method and a competitive protein binding assay kit for the determination of plasma hydroxycorticosteroids. Ann Clin Biochem 1975; 12:160.
  10. Papanicolaou DA, Yanovski JA, Cutler GB Jr, et al. A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 1998; 83:1163.
  11. Bright GM, Darmaun D. Corticosteroid-binding globulin modulates cortisol concentration responses to a given production rate. J Clin Endocrinol Metab 1995; 80:764.
  12. Brien TG. Human corticosteroid binding globulin. Clin Endocrinol (Oxf) 1981; 14:193.
  13. Coolens JL, Van Baelen H, Heyns W. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem 1987; 26:197.
  14. Musa BU, Seal US, Doe RP. Elevation of certain plasma proteins in man following estrogen administration: a dose-response relationship. J Clin Endocrinol Metab 1965; 25:1163.
  15. PETERSON RE, NOKES G, CHEN PS Jr, BLACK RL. Estrogens and adrenocortical function in man. J Clin Endocrinol Metab 1960; 20:495.
  16. Aron DC, Tyrrell JB, Fitzgerald PA, et al. Cushing's syndrome: problems in diagnosis. Medicine (Baltimore) 1981; 60:25.
  17. Fernández-Real JM, Grasa M, Casamitjana R, et al. Plasma total and glycosylated corticosteroid-binding globulin levels are associated with insulin secretion. J Clin Endocrinol Metab 1999; 84:3192.
  18. McCann VJ, Fulton TT. Cortisol metabolism in chronic liver disease. J Clin Endocrinol Metab 1975; 40:1038.
  19. Ramirez G, Gomez-Sanchez C, Meikle WA, Jubiz W. Evaluation of the hypothalamic hypophyseal adrenal axis in patients receiving long-term hemodialysis. Arch Intern Med 1982; 142:1448.
  20. Smith SR, Bledsoe T, Chhetri MK. Cortisol metabolism and the pituitary-adrenal axis in adults with protein-calorie malnutrition. J Clin Endocrinol Metab 1975; 40:43.
  21. Franks RC. Diurnal variation of plasma 17-hydroxycorticosteroids in children. J Clin Endocrinol Metab 1967; 27:75.
  22. HILLMAN DA, GIROUD CJ. PLASMA CORTISONE AND CORTISOL LEVELS AT BIRTH AND DURING THE NEONATAL PERIOD. J Clin Endocrinol Metab 1965; 25:243.
  23. Pfohl B, Sherman B, Schlechte J, Stone R. Pituitary-adrenal axis rhythm disturbances in psychiatric depression. Arch Gen Psychiatry 1985; 42:897.
  24. Pfohl B, Sherman B, Schlechte J, Winokur G. Differences in plasma ACTH and cortisol between depressed patients and normal controls. Biol Psychiatry 1985; 20:1055.
  25. Schlechte JA, Coffman T. Plasma free cortisol in depressive illness--a review of findings and clinical implications. Psychiatr Med 1985; 3:23.
  26. Fink RS, Short F, Marjot DH, James VH. Abnormal suppression of plasma cortisol during the intravenous infusion of dexamethasone to alcoholic patients. Clin Endocrinol (Oxf) 1981; 15:97.
  27. Ho JT, Al-Musalhi H, Chapman MJ, et al. Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab 2006; 91:105.
  28. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004; 350:1629.
  29. Migeon CJ, Lawrence B, Bertrand J, Holman GH. In vivo distribution of some 17-hydroxycorticoids between the plasma and red blood cells of man. J Clin Endocrinol Metab 1959; 19:1411.
  30. Newsome HH Jr, Clements AS, Borum EH. The simultaneous assay of cortisol, corticosterone, 11-deoxycortisol, and cortisone in human plasma. J Clin Endocrinol Metab 1972; 34:473.
  31. Robin P, Predine J, Milgrom E. Assay of unbound cortisol in plasma. J Clin Endocrinol Metab 1978; 46:277.
  32. Huang W, Kalhorn TF, Baillie M, et al. Determination of free and total cortisol in plasma and urine by liquid chromatography-tandem mass spectrometry. Ther Drug Monit 2007; 29:215.
  33. Arafah BM, Nishiyama FJ, Tlaygeh H, Hejal R. Measurement of salivary cortisol concentration in the assessment of adrenal function in critically ill subjects: a surrogate marker of the circulating free cortisol. J Clin Endocrinol Metab 2007; 92:2965.
  34. Anderson DC, Hopper BR, Lasley BL, Yen SS. A simple method for the assay of eight steroids in small volumes of plasma. Steroids 1976; 28:179.
  35. New MI, Lorenzen F, Lerner AJ, et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 1983; 57:320.
  36. White PC, New MI, Dupont B. Congenital adrenal hyperplasia. (1). N Engl J Med 1987; 316:1519.
  37. McKenna TJ, Moore G, Orth DN, et al. The biosynthesis of androgens in 21-hydroxylase deficiency. In: Adrenal Androgens, Genazzani AR, Thijssen JHH, Siiteri PK (Eds), Raven Press, New York 1980. p.135.
  38. Meikle AW, West SC, Weed JA, Tyler FH. Single dose metyrapone test: 11 beta-hydroxylase inhibition by metyrapone and reduced metyrapone assayed by radioimmunoassay. J Clin Endocrinol Metab 1975; 40:290.
  39. Bertagna C, Orth DN. Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). Am J Med 1981; 71:855.
  40. Walker RF, Riad-Fahmy D, Read GF. Adrenal status assessed by direct radioimmunoassay of cortisol in whole saliva or parotid saliva. Clin Chem 1978; 24:1460.
  41. Umeda T, Hiramatsu R, Iwaoka T, et al. Use of saliva for monitoring unbound free cortisol levels in serum. Clin Chim Acta 1981; 110:245.
  42. Chen YM, Cintrón NM, Whitson PA. Long-term storage of salivary cortisol samples at room temperature. Clin Chem 1992; 38:304.
  43. Laudat MH, Cerdas S, Fournier C, et al. Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function. J Clin Endocrinol Metab 1988; 66:343.
  44. Allolio B, Hoffmann J, Linton EA, et al. Diurnal salivary cortisol patterns during pregnancy and after delivery: relationship to plasma corticotrophin-releasing-hormone. Clin Endocrinol (Oxf) 1990; 33:279.
  45. Raff H, Raff JL, Findling JW. Late-night salivary cortisol as a screening test for Cushing's syndrome. J Clin Endocrinol Metab 1998; 83:2681.
  46. Raff H, Homar PJ, Burns EA. Comparison of two methods for measuring salivary cortisol. Clin Chem 2002; 48:207.
  47. Viera, JG, Noguti KO, Hidal, JT, et al. Measurement of saliva cortisol as a method for the evaluation of free serum fraction. Arq Bras Endocrinol Metab 1984; 28:8.
  48. Castro M, Elias PC, Quidute AR, et al. Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests. J Clin Endocrinol Metab 1999; 84:878.
  49. Liu H, Bravata DM, Cabaccan J, et al. Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans. Clin Endocrinol (Oxf) 2005; 63:642.
  50. Baid SK, Sinaii N, Wade M, et al. Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J Clin Endocrinol Metab 2007; 92:3102.
  51. Evans PJ, Peters JR, Dyas J, et al. Salivary cortisol levels in true and apparent hypercortisolism. Clin Endocrinol (Oxf) 1984; 20:709.
  52. Hermus AR, Pieters GF, Borm GF, et al. Unpredictable hypersecretion of cortisol in Cushing's disease: detection by daily salivary cortisol measurements. Acta Endocrinol (Copenh) 1993; 128:428.
  53. Mosnier-Pudar H, Thomopoulos P, Bertagna X, et al. Long-distance and long-term follow-up of a patient with intermittent Cushing's disease by salivary cortisol measurements. Eur J Endocrinol 1995; 133:313.
  54. Papanicolaou DA, Mullen N, Kyrou I, Nieman LK. Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 2002; 87:4515.